Cardiovascular, Kidney, and Mortality Outcomes With Finerenone in Patients With Cardiovascular-Kidney-Metabolic Syndrome
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes
Nat. Med. 2024 Sep 01;[EPub Ahead of Print], M Vaduganathan, G Filippatos, BL Claggett, AS Desai, PS Jhund, A Henderson, M Brinker, P Kolkhof, P Schloemer, J Lay-Flurrie, P Viswanathan, CSP Lam, M Senni, SJ Shah, AA Voors, F Zannad, P Rossing, LM Ruilope, SD Anker, B Pitt, R Agarwal, JJV McMurray, SD SolomonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.